ACTRN12619001752156
Recruiting
Phase 4
Clarifying the role of methylphenidate on distractor processing through event-related potentials in healthy controls.
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Symptoms of inattention
- Sponsor
- Monash University
- Enrollment
- 35
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All four grandparents Caucasian \- to ensure consistency in drug absorption rates
- •Right handed \- to reduce noise associated with differences in organisation of brain function
- •Females taking combined oral contraceptive pill \- to control for any differing absorption rates that may be the result of fluctuating hormones
Exclusion Criteria
- •\- Pregnant or breastfeeding \- to prevent any potential risk of harm methylphenidate may cause for unborn or newborn children
- •\- History of psychiatric or neurological illness (including head injuries) \- such conditions may confound results
- •\- Use of psychotropic medication or significant drug use \- could confound results, as any possible alteration in brain function from previous drug use may interfere with substances administered in this study
- •\- Current smokers \- May influence sensitivity of nicotine receptors
- •\- Alcohol dependence (more than 24 units/week) \- may influence dopamine receptor availability or sensitivity
- •\- Individuals with contraindications to methylphenidate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Investigating the effect of methylphenidate on the level of consciousness in loss of consciousness patients due to poisoningIRCT20220305054196N4Shahid Beheshti University of Medical Sciences64
Terminated
Phase 4
Efficacy of methylphenidate and Attention Process Training in traumatic brain injury rehabilitatioTraumatic Brain Injury (TBI)Injuries and Accidents - Other injuries and accidentsPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationNeurological - Other neurological disordersACTRN12612000484842Monash University160
Not yet recruiting
Phase 3
Investigating the effect of methylphenidate on increasing the level of consciousness in patients with hypoxic ischemic encephalopathyIRCT20220924056025N1Qazvin Medical Sciences Research Deputy48
Recruiting
Phase 2
The effects of methylphenidate and atomoxetine on emotional intelligence, executive function and self-efficacy of 12-18-year-old adolescents with ADHDIRCT20160523028008N31Hamedan University of Medical Sciences76
Completed
Phase 3
Evaluation of the effect of Methylphenidate on consciousness in patients ?with brain damage in ICBrain damage.Unspecified brain damage due to birth injuryP11.2IRCT20141209020258N128Arak University of Medical Sciences90